Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer

Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer

Introduction: Early-activated RAS/RAF mutation status is a key molecular finding in colorectal cancer (CRC), while these mutations have been proposed as predictive and prognostic biomarkers. The present study has been designed as a longitudinal study to evaluate and summarize the different genotypes...

Full description

Bibliographic Details
Main Authors: Roya Dolatkhah, Saeed Dastgiri, Amir Taher Eftekhar Sadat, Faris Farassati, Marzieh Nezamdoust, Mohammad Hossein Somi
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2021-01-01
Series:BioImpacts
Subjects:
colorectal cancer
overall survival
oncogene
kras
hazard ratio
Online Access:https://bi.tbzmed.ac.ir/PDF/bi-11-5.pdf

Internet

https://bi.tbzmed.ac.ir/PDF/bi-11-5.pdf

Similar Items